Sign Out
Pregnancy: Category D. Adverse effects were observed in animal reproduction studies. Fetal harm may occur if administered during pregnancy. Women of child bearing potential should use effective contraceptives to avoid pregnancy during treatment.
Lactation: It is not known if capecitabine is excreted in human breast milk. In lactating mice, considerable amounts of capecitabine and its metabolites were found in milk. Breast-feeding should be discontinued while receiving treatment with capecitabine.
Continue with Google